Johnson & Johnson press releases
The latest press releases from Johnson & Johnson (NYSE: JNJ), gathered from its own newsroom and from the newswires that carry it. PPN World follows 1,400+ press release feeds and adds each Johnson & Johnson release within minutes of publication.
- Listing
- NYSE: JNJ
- Latest release
- Nov 6, 2026
- On this page
- 20 newest releases
Latest Johnson & Johnson press releases
- Johnson & Johnson announces U.S. FDA Approval of RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) as First and Only Dual-Targeted Therapy for Advanced Head and Neck Cancer
Accelerated approval based on data demonstrating clinically meaningful efficacy, including a 42 percent overall response rate (95 percent confidence interval, 32–52 percent)1 First advancement in the…
- Johnson & Johnson to Host Enterprise Business Review
Johnson & Johnson to Host Enterprise Business Review
- RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) combination demonstrates 77% overall response rate in first-line treatment of patients with advanced head and neck cancer
Responses were deep and durable, with 65% ongoing at clinical cutoff Results support continued evaluation of the investigational RYBREVANT FASPRO regimen in the ongoing first-line Phase 3 study Data h…
The first 3 are open to everyone. A free account shows the rest and emails you the next Johnson & Johnson release the minute it is out.
PPN World is independent and not affiliated with Johnson & Johnson. Headlines and short excerpts only; each release links to its source.
Questions
Where can I find Johnson & Johnson press releases?+
How do I get an alert when Johnson & Johnson publishes a press release?+
Is this Johnson & Johnson's official newsroom?+
Know the minute Johnson & Johnson publishes
Watch Johnson & Johnson, its competitors and its sector in one live feed, with email alerts — on the free plan.